Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine for depression after TBI
NCT00205491Phase 4Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Oct 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of venlafaxine in major depressive disorder (MDD), sponsored by Virginia Commonwealth University. Started Oct 2004; status: completed.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00205491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00205491.